A similar finding was observed in primary human dermal fibroblasts (HDFs), whereby FGF-2 with TGF-β1 cotreatment, both positively and negatively regulated fibroblast transition into cancer-associated fibroblasts (CAFs) [77]. The gene discussed is TGFB1; the disease is cancer.